Literature DB >> 18948386

The importance of test positive predictive value in ovarian cancer screening.

Mark H Greene, Ziding Feng, Mitchell H Gail.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18948386     DOI： 10.1158/1078-0432.CCR-08-2232

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  11 in total

Review 1.  Protein biomarkers of ovarian cancer: the forest and the trees.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Future Oncol       Date:  2012-01       Impact factor: 3.404

Review 2.  Molecular signatures of ovarian cancer: from detection to prognosis.

Authors:  Christine S Walsh; Beth Y Karlan
Journal:  Mol Diagn Ther       Date:  2010-02-01       Impact factor: 4.074

3.  Cancer: Missing the mark.

Authors:  Lizzie Buchen
Journal:  Nature       Date:  2011-03-24       Impact factor: 49.962

4.  Challenges related to developing serum-based biomarkers for early ovarian cancer detection.

Authors:  Phuong L Mai; Nicolas Wentzensen; Mark H Greene
Journal:  Cancer Prev Res (Phila)       Date:  2011-03

Review 5.  Proteomics and ovarian cancer: integrating proteomics information into clinical care.

Authors:  John L Hays; Geoffrey Kim; Iulia Giuroiu; Elise C Kohn
Journal:  J Proteomics       Date:  2010-06-01       Impact factor: 4.044

Review 6.  Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review.

Authors:  Juliane M Liberto; Sheng-Yin Chen; Ie-Ming Shih; Tza-Huei Wang; Tian-Li Wang; Thomas R Pisanic
Journal:  Cancers (Basel)       Date:  2022-06-11       Impact factor: 6.575

Review 7.  Biomarker testing for ovarian cancer: clinical utility of multiplex assays.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Mol Diagn Ther       Date:  2013-06       Impact factor: 4.074

8.  Beyond CA125: the coming of age of ovarian cancer biomarkers. Are we there yet?

Authors:  Dimitra Sasaroli; George Coukos; Nathalie Scholler
Journal:  Biomark Med       Date:  2009-06-01       Impact factor: 2.851

9.  Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkers.

Authors:  Yong-Wan Kim; Su Mi Bae; Hyunsun Lim; Yoon Ji Kim; Woong Shick Ahn
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

10.  Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.

Authors:  Lisa M McShane; Margaret M Cavenagh; Tracy G Lively; David A Eberhard; William L Bigbee; P Mickey Williams; Jill P Mesirov; Mei-Yin C Polley; Kelly Y Kim; James V Tricoli; Jeremy M G Taylor; Deborah J Shuman; Richard M Simon; James H Doroshow; Barbara A Conley
Journal:  BMC Med       Date:  2013-10-17       Impact factor: 11.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.